首页|可溶性肾素/肾素原受体在心血管疾病和肾脏疾病中的研究进展

可溶性肾素/肾素原受体在心血管疾病和肾脏疾病中的研究进展

扫码查看
肾素/肾素原受体(PRR)是肾素-血管紧张素系统的重要组成部分,参与人体的多种病理生理过程,并且其可溶形式是由位点-1蛋白酶切割形成的相对分子质量28 000的蛋白质,即sPRR。近年来越来越多的研究证明sPRR与心血管疾病和肾脏疾病的发生和进展有密切联系,这就为其成为这些疾病新型的生物标志物或治疗靶点提供了可能性。由于尿崩症、心力衰竭等疾病缺乏针对性特效药且现有治疗效果不佳,因此进一步了解sPRR参与这些疾病的具体机制有利于提供全新的诊治方向。现旨在对sPRR的结构、功能以及在心血管疾病和肾脏疾病中的研究进展进行综述。
Soluble Renin/Prorenin Receptor in Cardiovascular Disease and Kidney Disease
Renin/prorenin receptor(PRR)is an important part of renin-angiotensin system,involved in a variety of human pathophysiological processes,and its soluble form is a protein with a relative molecular weight of 28 000 cleaved by site-1 protease,namely sPRR.In recent years,more and more studies have proved that sPRR is closely related to the occurrence and progression of cardiovascular disease and kidney disease,which provides the possibility for it to become a novel biomarker or therapeutic target for these diseases.Due to the lack of specific drugs for diabetes insipidus,heart failure and other diseases,and the poor effect of existing treatments,further understanding of the specific mechanism of sPRR involvement in these diseases is conducive to providing a new direction for diagnosis and treatment.This article aims to review the structure,function and research progress of sPRR in cardiovascular disease and kidney disease.

Soluble renin/prorenin receptorHypertensionHeart failureAquaporin 2

陈妍羽、刘洁、陈燕、彭华

展开 >

华中科技大学同济医学院附属协和医院儿科,湖北武汉 430022

可溶性肾素/肾素原受体 高血压 心力衰竭 水孔蛋白2

湖北省自然科学基金湖北省自然科学基金湖北省重点研发计划

2020CFB7642020CFB8132022BCA043

2024

心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
年,卷(期):2024.45(8)